Skip to main content
All lobbying filings

ALTRIA CLIENT SERVICES LLC

Lobbying for ALTRIA CLIENT SERVICES LLC

 Filing 2nd Quarter - Report
2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate · $3,200,000.00 expenses · posted Jul 20, 2026

Official filing document

 Bills named in this filing 11
  • HR 8646
    Agriculture, Rural Development, Food and Drug Administration, and Related Agency Appropriations Act, 2027
  • HR 9310
    Department of Homeland Security Appropriations Act, 2027
  • HR 8260
    Hospital Inpatient Services Modernization Act
  • HR 8845
    Commerce, Justice, Science, and Related Agencies Appropriations Act, 2027
  • HR 8495
    Financial Services and General Government Appropriations Act, 2027
  • HR 8595
    National Security, Department of State, and Related Programs Appropriations Act, 2027
  • HR 9170
    Transportation, Housing and Urban Development, and Related Agencies Appropriations Act, 2027
  • HR 6938
    Commerce, Justice, Science; Energy and Water Development; and Interior and Environment Appropriations Act, 2026
  • HR 1798
    End Tobacco Loopholes Act
  • HR 3838
    Streamlining Procurement for Effective Execution and Delivery and National Defense Authorization Act for Fiscal Year 20…
  • HR 6845
    S.T.O.P. Illicit Vapes Act
 Lobbying activity 2
Budget/Appropriations

HR 8646: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act 2027; Section 766, related to provisions regarding the regulation of tobacco products and provisions to address and prohibit the importation and sale of illicit flavored, disposable electronic nicotine delivery system (ENDS) products HR 9310: Department of Homeland Security Appropriations Act 2027; potential provisions related to tobacco and nicotine products HR 8260/S 2587: Departments of Labor, Health and Human Services and Education and Related Agencies Appropriations Act 2027; potential provisions related to tobacco and nicotine products HR 8845/S 2354: Commerce Justice Science and Related Agencies Appropriations Act 2027; potential provisions related to tobacco and nicotine products HR 8495: Financial Services and General Government Appropriations Act, 2027; related to provisions to address and prohibit the importation and sale of illicit flavored, disposable electronic nicotine delivery system (ENDS) products HR 8595: National Security, Department of State, and Related Programs Appropriations Act, 2027; related to provisions to address and prohibit the importation and sale of illicit flavored, disposable electronic nicotine delivery system (ENDS) products HR 9170: Transportation Housing and Urban Development and Related Agencies Appropriations Act 2027; potential provisions related to tobacco and nicotine products HR 6938: FY2026 Consolidated Commerce Justice Science, Energy & Water, Interior Appropriations Act; provisions related to contraband vapor products and the Organized Crime Drug Enforcement Task Force S 2256: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act 2027; potential provisions related to tobacco and nicotine products

Tobacco

HR 1798/ S 819: End Tobacco Loopholes Act; all provisions of the bill HR 3838: Streamlining Procurement for Effective Execution and Delivery and National Defense Authorization Act for Fiscal Year 2026; provisions relating to enforcement efforts regarding illicit e-cigarettes and other unauthorized tobacco products Implementation of P.L. 111-31 Family Smoking Prevention and Tobacco Control Act Implementation of P.L. 117-103 Consolidated Appropriations Act, 2022; provisions related to providing FDA authority to regulate products containing synthetic nicotine Discussions related to tobacco harm reduction and pathways to authorization for tobacco and nicotine products Discussions concerning proposals to ban characterizing flavors in tobacco products Discussions regarding the FDAs need to urgently implement a compliance and enforcement plan to address and prohibit the importation and sale of illicit flavored, disposable electronic nicotine delivery system (ENDS) products Discussions concerning nicotine analogue products and FDAs regulatory authority over such products Discussions regarding federal excise taxes and the taxation of tobacco products HR 6845: S.T.O.P. Illicit Vapes Act; all provisions of the bill S 3213: Destruction of Hazardous Imports Act; all provisions of the bill S 4303: ENDS Chinese Vapes Act of 2026; all provisions of the bill Discussions related to FDA Guidance on Enforcement Priorities for Certain New Tobacco Products Marketed Without Premarket Authorization

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem